A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)
Incyte Corporation
Incyte Corporation
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Vanderbilt-Ingram Cancer Center